Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)
Harmony Biosciences Holdings' (HRMY) quarterly Preferred Dividend Payments came in at $6.0 million in Q3 2020, down 33.39% year-on-year from $9.0 million in Q4 2019, and down 42.44% quarter-over-quarter from $10.4 million in Q2 2020.
Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Harmony Biosciences Holdings has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $6.0 million for Q3 2020.
- Preferred Dividend Payments for Q3 2020 came in at $6.0 million, down 33.39% year-over-year; the trailing twelve-month figure through Dec 2020 was $26.9 million (changed N/A YoY), and the FY2020 annual result was $26.9 million, down 23.64% from the prior year.
- Preferred Dividend Payments came in at $6.0 million for Q3 2020 at Harmony Biosciences Holdings, down from $10.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $10.4 million in Q2 2020 to a low of $6.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 6.01 Mn |
| Jun 30, 2020 | 10.45 Mn |
| Mar 31, 2020 | 10.45 Mn |
| Dec 31, 2019 | 9.58 Mn |
| Sep 30, 2019 | 9.03 Mn |